7812
D.J.-Y.D. Bon et al. / Tetrahedron 66 (2010) 7807e7814
2.73e2.63 (m, 1H), 2.22 (dd, J¼11.2 and 8.8 Hz,1H), 2.07 (s, 3H),1.63
(dd, J¼12.8 and 8.0 Hz, 1H), 1.19 (s, 3H) 1.19e1.08 (m, 1H), 0.91
J¼10.4 and 5.2 Hz, 1H), 2.05 (s, 3H), 2.06e1.97 (m, 1H), 1.84 (dd,
J¼10.0 and 6.0 Hz, 1H), 1.39 (dd, J¼13.6 and 6.4 Hz, 1H), 1.17 (s, 3H),
(s, 3H), 0.90 (s, 3H); 13C NMR (CDCl3, 75 MHz)
d
211.4, 170.7, 140.3,
1.02 (s, 3H), 0.90 (s, 3H); 13C NMR (CDCl3, 75 MHz)
d 209.5, 170.8,
127.0, 81.5, 74.1, 50.9, 50.5, 44.2, 41.5, 41.3, 36.3, 25.8, 22.1, 21.2, 17.1;
165.7, 133.5, 130.0, 129.4, 128.6, 84.8, 80.1, 61.2, 50.8, 44.5, 43.5, 41.1,
39.7, 39.1, 38.7, 26.8, 22.0, 21.3, 14.1; nmax (KBr) 2962, 1734, 1602,
1451, 1369, 1266, 1242, 1095, 711 cmꢀ1; MS (ESI, þve ion) m/z 787
[(2 MþNa)þ, 8%], 405 [(MþNa)þ, 100%], 383 [(MþH)þ, 15], 173 (38).
Concentration of fraction C (Rf¼0.4 in 1:4 v/v ethyl acetate/
hexane) gave the starting keto-benzoate 13 (102 mg, 24% recovery)
as a white, crystalline solid that was identical, in all respects, with
an authentic sample.
nmax (KBr) 3401, 2961, 2873, 1736, 1464, 1373, 1241, 1036, 725 cmꢀ1
;
MS (EI, 70 eV) m/z 278 (Mþꢃ, 11%), 218 (73), 203 (67), 175 (42), 161
(68), 159 (55), 145 (74), 105 (67), 95 (60), 43 (100).
Step ii: A magnetically stirred solution of the acyloin (90 mg,
0.32 mmol, formed in step i), triethylamine (1 mL) and 4-(N,N-
dimethylamino)pyridine (129 mg, 1.06 mmol) in dichloro-methane
(5 mL) was cooled to 0 ꢁC then treated with benzoyl chloride (92
mL,
0.79 mmol). The resulting mixture was allowed to warm to 18 ꢁC,
stirred at this temperature for 16 h then treated with HCl (20 mL of
a 1 M aqueous solution) and extracted with dichloromethane
(4ꢂ15 mL). The combined organic extracts were dried (MgSO4),
filtered, and concentrated under reduced pressure to give a light-
yellow oil that was subjected to flash column chromatography
(silica gel, 1:13.3/1:9 v/v ethyl acetate/hexane gradient elution).
Concentration of the relevant fractions (Rf¼0.4 in 1:4 v/v ethyl ac-
etate/hexane) then gave the keto-benzoate 13 (111 mg, 91%) as
4.2.7. Compound 15. A magnetically stirred solution of either epi-
meric form of compound 14 (161 mg, 0.42 mmol), or a mixture
thereof, in THF/methanol (8 mL of a 2:1 v/v mixture) was cooled to
ꢀ78 ꢁC and, while being maintained under an argon atmosphere,
was treated with samarium(II) iodide (9.27 mL of a 0.1 M solution
in THF, 0.93 mmol) by dropwise addition until a blue color persisted
for w10 min. After this time the reaction mixture was quenched
with potassium carbonate (10 mL of saturated aqueous solution)
and extracted with diethyl ether (3ꢂ2 mL). The combined organic
extracts were then washed with water (1ꢂ5 mL) and brine
(1ꢂ5 mL) before being dried (Na2SO4), filtered, and concentrated
under reduced pressure to give a light-yellow oil that was subjected
to flash column chromatography (silica gel, 1:4 v/v ethyl acetate/
hexane elution). Concentration of the relevant fractions (Rf¼0.3 in
1:3 v/v ethyl acetate/hexane) then gave the title compound 15
a white, crystalline solid, mp¼111e114 ꢁC, [
D þ170.4 (c 1.1, CHCl3)
a
]
(Found: Mþꢃ, 382.1772. C23H26O5 requires Mþꢃ, 382.1780). 1H NMR
(CDCl3, 400 MHz)
d
8.02e7.97 (m, 2H), 7.58e7.53 (tm, J¼7.6 Hz, 1H),
7.45e7.39 (m, 2H), 6.30e6.20 (m, 2H), 5.11 (s, 1H), 4.80 (d, J¼8.4 Hz,
1H), 3.20e3.14 (m, 1H), 2.86e2.76 (m, 1H), 2.44 (dd, J¼10.8 and
8.8 Hz, 1H), 2.07 (s, 3H), 1.69 (dd, J¼12.8 and 8.0 Hz, 1H), 1.27e1.18
(m, 1H), 1.10 (s, 3H), 0.96 (s, 3H), 0.94 (s, 3H); 13C NMR (CDCl3,
75 MHz)
d
205.1, 170.7, 166.2, 139.5, 133.4, 130.0, 129.3, 128.5, 127.8,
(90 mg, 81%) as a white, crystalline solid, mp¼126e129 ꢁC, [
a]
D
81.5, 73.7, 51.6, 50.3, 43.4, 41.6, 41.4, 36.7, 25.9, 22.2, 21.3, 17.2; nmax
(KBr) 2965, 2873, 1738, 1693, 1451, 1375, 1270, 1241, 1109, 1043,
771 cmꢀ1; MS (EI, 70 eV) m/z 382 (Mþꢃ, 4%), 226 (29), 200 (68), 198
(57), 160 (70), 145 (63), 122 (100), 121 (75), 106 (83), 105 (98), 77
(90), 51 (93), 50 (64), 43 (64).
þ68.1 (c 0.8, CHCl3) [Found: (MþH)þ, 263.1642. C16H22O3 requires
(MþH)þ, 263.1647]. 1H NMR (CDCl3, 400 MHz)
5.03 (d, J¼10.0 Hz,
d
1H), 2.60e2.54 (m, 1H), 2.41 (t, J¼5.2 Hz, 1H), 2.33 (dd, J¼17.6 and
1.2 Hz, 1H), 2.26 (dd, J¼10.0 and 7.6 Hz, 1H), 2.05 (s, 3H), 2.00e1.94
(m, 3H), 1.69e1.62 (m, 1H), 1.34 (dd, J¼13.6 and 6.4 Hz, 1H), 1.25 (s,
3H), 0.98 (s, 3H), 0.83 (s, 3H); 13C NMR (CDCl3, 75 MHz)
d 214.3,
4.2.6. Compound 14. A deoxygenated solution of compound 13
(428 mg, 1.12 mmol) and acetophenone (180 mL, 1.54 mmol) in ac-
170.7, 80.5, 64.3, 57.7, 46.9, 44.7, 43.0, 39.7, 39.5, 38.9, 38.5, 26.9,
22.1, 21.3, 21.1; nmax (KBr) 2942, 1716, 1378, 1244, 1041, 961,
886 cmꢀ1; MS (ESI, þve ion) m/z 285 [(MþNa)þ, 15%], 263 [(MþH)þ,
<1], 102 (100).
etone (200 mL) was placed in a QuartexÔ immersion well photo-
reactor (500 mL reactor from Ace Glass Inc.) equipped with
a PyrexÔ filter. The solution was subjected to irradiation with
a Hanovia 450 W medium pressure mercury-vapor lamp for 3.5 h
and then cooled and concentrated under reduced pressure to give
a pale-yellow oil. Subjection of this material to flash column
chromatography (silica gel, 1:20/1:4 v/v ethyl acetate/hexane
gradient elution) afforded three fractions, A, B and C.
4.2.8. Compound 16. A magnetically stirred solution of ketone 15
(86 mg, 0.33 mmol) in THF (4.4 mL) maintained at ꢀ78 ꢁC under an
argon atmosphere was treated, dropwise, with LiHMDS (394 mL of
a 1 M THF solution, 0.39 mmol) and the resulting mixture left to stir
at ꢀ78 ꢁC for 1 h. After this time, Eschenmoser’s salt (182 mg,
0.98 mmol) was added, in one portion, to the reaction mixture,
which was then allowed to warm to 18 ꢁC over 16 h before being
quenched with HCl (10 mL of a 3 M aqueous solution) and, after
5 min., extracted with diethyl ether (3ꢂ10 mL). The separated
aqueous phase was basified, to pH 14, then extracted with
dichloromethane (3ꢂ10 mL). The combined organic extracts were
dried (Na2SO4), filtered, and concentrated under reduced pressure
to afford the title amine 16 (75 mg, 71%) as a white, crystalline solid,
Concentration of fraction A (Rf¼0.25 in 1:4 v/v ethyl acetate/
hexane) gave the C1-b epimeric form of compound 14 (165 mg, 51%
at 76% conversion) as a white, crystalline solid, mp¼135e136 ꢁC,
[
a
]
þ14.9 (c 1.0, CHCl3) [Found: (MþH)þ, 383.1858. C23H26O5 re-
D
quires (MþH)þ, 383.1858]. 1H NMR (CDCl3, 400 MHz)
d 8.08e8.04
(m, 2H), 7.60 (t, J¼8.0, Hz, 1H), 7.50e7.46 (m, 2H), 5.35 (d, J¼4.0 Hz,
1H), 5.13 (d, J¼12.0 Hz, 1H), 2.75 (dd, J¼12.0 and 8.0 Hz, 1H),
2.58e2.50 (m, 1H), 2.35 (t, J¼4.0 Hz, 1H), 2.06e2.00 (m, 1H), 2.01
(s, 3H), 1.98e1.94 (m, 1H), 1.82 (dd, J¼12.0 and 8.0 Hz, 1H), 1.42 (dd,
J¼12.0 and 6.4 Hz, 1H), 1.36 (s, 3H), 1.01 (s, 3H), 0.90 (s, 3H); 13C
mp¼110e114 ꢁC, Rf¼0.7 in 1:3 v/v ethyl acetate/hexane, [
D ꢀ64.3
a
]
(c 1.0, CHCl3) [Found: (MþH)þ, 320.2224. C19H29NO3 requires
NMR (CDCl3, 75 MHz)
d
205.6, 170.7, 165.4, 133.5,130.0, 129.5, 128.6,
(MþH)þ, 320.2226]. 1H NMR (CDCl3, 400 MHz)
5.04 (d, J¼13.2 Hz,
d
83.7, 80.0, 55.7, 49.4, 44.3, 43.1, 38.9, 36.0, 33.7, 32.1, 26.7, 21.8, 21.3,
19.6; nmax (KBr) 2960, 2929, 2873, 1727, 1452, 1370, 1269, 1241, 1110,
1042, 710 cmꢀ1; MS (ESI, þve ion) m/z 405 [(MþNa)þ, 100%] 383
[(MþH)þ, 11].
1H), 2.60e2.52 (m, 1H), 2.46e2.35 (m, 2H), 2.28e2.20 (m, 2H), 2.18
(s, 6H), 2.08e1.98 (m, 1H), 2.03 (s, 3H), 1.96e1.86 (m, 2H), 1.63 (dd,
J¼10.4 and 6.0 Hz, 1H), 1.25 (dd, J¼13.2 and 6.8 Hz, 1H), 1.16 (s, 3H),
0.95 (s, 3H) 0.80 (s, 3H); 13C NMR (CDCl3, 75 MHz)
d 214.7, 170.5,
Concentration of fraction B (Rf¼0.35 in 1:4 v/v ethyl acetate/
80.2, 64.7, 62.2, 59.8, 49.6, 45.6, 44.2, 42.9, 38.6, 38.4, 37.7, 36.4,
26.6, 21.6, 21.2, 15.9; nmax (KBr) 2960, 2866, 2822, 2768, 1732, 1455,
1369, 1241, 1040, 900, 819, 736 cmꢀ1; MS (ESI, þve ion) m/z 320
[(MþH)þ, 25%], 58 (97), 57 (100).
hexane) gave the C1-a epimeric form of compound 14 (143 mg, 44%
at 76% conversion) as a white, crystalline solid, mp¼139e150 ꢁC,
[
a
]
þ18.6 (c 1.0, CHCl3) [Found: (MþNa)þ, 405.1671. C23H26O5 re-
D
quires (MþNa)þ, 405.1678]. 1H NMR (CDCl3, 400 MHz)
d 8.06e8.02
(m, 2H), 7.58 (t, J¼7.6 Hz, 1H), 7.47e7.41 (m, 2H), 5.14 (d, J¼9.6 Hz,
1H), 4.97 (s, 1H), 2.70e262 (m, 1H), 2.60e2.50 (m, 2H), 2.22 (dd,
4.2.9. Compound 17. A magnetically stirred solution of tertiary
amine 16 (195 mg, 0.61 mmol) in diethyl ether/dichloromethane